The global guillain-barre syndrome market size was estimated at USD 729.70 million in 2024 and is projected to reach USD 1,039.99 million by 2030, growing at a CAGR of 6.10% from 2025 to 2030. This growth is largely driven by an increasing number of GBS cases, especially in areas with a high prevalence of infectious diseases, which is anticipated to significantly boost demand for...